Actively Recruiting
Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study
Led by Caijie Shen · Updated on 2024-10-24
428
Participants Needed
1
Research Sites
141 weeks
Total Duration
On this page
Sponsors
C
Caijie Shen
Lead Sponsor
S
Shanghai MicroPort EP MedTech Co., Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this retrospective study is to compare the long-term follow-up outcomes of pulses field ablation (PFA) Vs. radiofrequency ablation (RFA) for the patients with paroxysmal supraventricular tachycardia (PSVT). The main question to answer is: Does the PFA was more effecient and safer that RFA for treatment of PSVT during procedure and after 1-year follow-up? Researchers will compare the acute and long-term efficiency and safety between PFA and RFA. 1. Recieved PFA or RFA 1 year ago 2. Finish the visit to the clinic at 1, 3, 6, 12 months for examinations and blood testings 3. Patients recieved PFA and PFA under propensity matched comparison according to differen variety of PSVT
CONDITIONS
Official Title
Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with symptomatic PSVT including atrioventricular nodal re-entrant tachycardia (AVNRT) or atrioventricular re-entrant tachycardia (AVRT)
- Age between 18 and 80 years, any gender
- Willing to undergo examinations and tests during one-year follow-up as required by the study
- Voluntarily signed informed consent
You will not qualify if you...
- Organic heart disease
- History of cardiac surgery
- Previous failed ablation of PSVT
- Presence of implants like a permanent pacemaker
- Invasive systemic infections or advanced malignant tumors
- Contraindications for septal puncture or retrograde transaortic access surgery
- Conditions preventing use of heparin or aspirin
- Pregnant or lactating women
- Inability to comply with study procedures or provide informed consent
- Coexisting arrhythmias such as atrial fibrillation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
the First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, China, 315000
Actively Recruiting
Research Team
C
Caijie Shen, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here